Nanozyme-mediated antioxidative therapy is a promising star for treating a myriad of
important diseases through eliminating excessive reactive oxygen species (ROS) such as …

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease
(CD), is a chronic and recurrent disease that seriously affects the life quality of patients …

Disturbed intestinal microbiota and abnormally high levels of reactive oxygen species (ROS)
in the colon are important factors in the pathogenesis of ulcerative colitis (UC). Therefore …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) of unknown etiology
affecting the colon and rectum. Previous studies have found that reactive oxygen species …

Background Ulcerative colitis (UC) is a chronic intestinal inflammation, resulting in a global
healthcare challenge with no real specific medicine. Natural medicines are recognized as a …

Inflammatory bowel disease (IBD) is a recurrent chronic colitis disease with increasing
incidence and prevalence year by year. The single efficacy and significant side effects of …

Oxidative stress is a growing concern, necessitating more effective antioxidants for complex
environments. Herein, we developed a composite nanozyme, DVI-CDs-Cu, with exceptional …

Developing an efficient antioxidant for anti-inflammatory therapy via scavenging reactive
oxygen species (ROS) remains a great challenge owing to the insufficient activity and …

Oxidative stress is associated with many acute and chronic inflammatory diseases, yet
limited treatment is currently available clinically. The development of enzyme-mimicking …

Background Ulcerative colitis (UC) is defined by persistent inflammatory processes within
the gastrointestinal tract of uncertain etiology. Current therapeutic approaches are limited in …